Home LiteratureArticle Details
PMID: 12606029 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

The pp60c-Src inhibitor PP1 is non-competitive against ATP.

FEBS letters ·Vol. 537 ·No. 1-3 ·2003-02-27 ·Pages 47-52

Karni R, Mizrachi S, Reiss-Sklan E, Gazit A, Livnah O, Levitzki A

Abstract

Glutathione-S-transferase (GST)-pp60(c-Src) (GST-Src) expressed in Escherichia coli is as catalytically active as purified, activated pp60(c-Src) protein derived from human platelets. We utilized the bacterially expressed enzyme, together with information about the structures of Src family kinases in complex with their inhibitors PP1 and PP2, to modify PP1 in a quest for improved inhibitors. Despite the detailed structural information on Hck-PP1 and Lck-PP2 complexes, which shows that PP1 and PP2 bind to the adenosine triphosphate (ATP) pocket, we were unable to improve the affinity between modified PP1 and Src. Puzzled, we examined in detail the mechanism by which PP1 inhibits the kinase activity of Src. Here we report that PP1 is non-competitive with ATP for the inhibition of Src, at variance with what is currently accepted, and is a 'mixed competitive inhibitor' vis-à-vis the substrate. These findings shed new light on the mechanism whereby PP1-like molecules inhibit Src. Examination of the homology between the kinase domain of Src and those of Hck and Lck reveals significant differences outside the ATP binding pocket, whereas they are identical within the ATP binding domain. These results suggest that PP1 may be a leading compound for ATP non-competitive inhibitors of Src family kinases. Since Src in its active form is the hallmark of numerous cancers, understanding how PP1 inhibits activated Src will aid in the discovery of potent and selective Src kinase inhibitors.

MeSH Terms
Adenosine Triphosphate/metabolism,pharmacology Adenylyl Imidodiphosphate/metabolism Blood Platelets Cloning, Molecular Enzyme Inhibitors/pharmacology Escherichia coli/genetics,metabolism Humans Kinetics Models, Molecular Phosphorylation Phosphotyrosine/metabolism Protein Structure, Secondary Proto-Oncogene Proteins pp60(c-src)/antagonists & inhibitors,chemistry Pyrazoles/pharmacology Pyrimidines/pharmacology Recombinant Fusion Proteins/antagonists & inhibitors,chemistry src-Family Kinases/antagonists & inhibitors
Chemicals
4-amino-5-(4-methylphenyl)-7-(tert-butyl)pyrazolo(3,4-d)pyrimidine AG 1879 Enzyme Inhibitors Pyrazoles Pyrimidines Recombinant Fusion Proteins Phosphotyrosine Adenylyl Imidodiphosphate Adenosine Triphosphate Proto-Oncogene Proteins pp60(c-src) src-Family Kinases
Authors & Affiliations
6 authors, click to expand affiliations / ORCID
Karni Rotem
Department of Biological Chemistry, The Alexander Silberman Institute of Life Sciences, The Hebrew University of Jerusalem, Israel.
Mizrachi Sarit
Reiss-Sklan Ella
Gazit Aviv
Livnah Oded
Levitzki Alexander
Article Info
Journal
FEBS letters
Abbr.
FEBS Lett
ISSN
0014-5793
Published
2003-02-27
Pages
47-52
Language
English
Region
England
NLM ID
0155157
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com